Açık Akademik Arşiv Sistemi

The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)